Mpi indium dtpa in 111?

Do you mean MPI as in myocardial perfusion imaging, or renography (kidney imaging)?

- In-111 DTPA is not used for myocardial perfusion imaging (MPI). MPI typically uses Tc-99m radiopharmaceuticals (like sestamibi or tetrofosmin) or Thallium-201.

If you’re asking about In-111 DTPA for renal imaging (renography):
- What it’s used for: assessing renal function, differential function between kidneys, and drainage/obstruction.
- Radioisotope properties: Indium-111 (half-life ~2.8 days) with gamma energies at 171 and 245 keV; imaging requires appropriate collimators and can use planar dynamic imaging or SPECT/CT.
- Typical use: dynamic renogram to derive function curves and estimate GFR or split renal function.
- Common protocol (high level): inject In-111 DTPA IV, acquire dynamic renal images (often 20–60 minutes of rapid frames, followed by delayed imaging up to a few hours), then analyze time-activity curves.
- Dosing (general guidance): activities are protocol- and patient-dependent; adult doses are commonly in the low mCi range (roughly 2–6 mCi, with adjustments for pediatric patients). Always follow your local protocol and dose reference.
- Advantages/limitations: useful for functional assessment and drainage; longer half-life means higher radiation dose and slower imaging compared to Tc-99m DTPA; lower resolution and more complex interpretation.

If you can clarify whether you meant MPI or renography, I can give more specific details (protocols, interpretation criteria, and any safety considerations).